Emerging as a promising development in the struggle against obesity, the drug is attracting considerable attention . This treatment combines properties of two recognized GLP-1 receptor agonists, dulaglutide , plus an additional glucose-dependent peptide component. Initial study findings have shown significant body loss in individuals with a high… Read More